Journal
FERTILITY AND STERILITY
Volume 99, Issue 4, Pages 1107-1116Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2012.11.038
Keywords
Ectopic pregnancy; biomarker; pregnancy of unknown location; proteomics
Categories
Funding
- National Institutes of Health
- Abbott
- Evofem, Inc.
- NIH [T32HD7440-16, K24HD060687]
Ask authors/readers for more resources
Early pregnancy failure is the most common complication of pregnancy, and 1% to 2% of all pregnancies will be ectopic. As one of the leading causes of maternal morbidity and mortality, diagnosing ectopic pregnancy and determining the fate of a pregnancy of unknown location are of great clinical concern. Several serum and plasma biomarkers for ectopic pregnancy have been investigated independently and in combination. The following is a review of the state of biomarker discovery and development for ectopic pregnancy and pregnancy of unknown location. (Fertil Steril (R) 2013;99:1107-16. (C) 2013 by American Society for Reproductive Medicine.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available